Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ricevuto

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Clinical Endocrinology|September 1, 1999
p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumoursM L Jaffrain-Rea, E Ferretti, E Toniato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Novel P53 mutations detected by FAMA in colorectal cancersF De Galitiis, K Cannita, A Tessitore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2007
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancerC Natoli, E Cianchetti, N Tinari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Prognostic value of p53 molecular status in high-risk primary breast cancerP Marchetti, K Cannita, E Ricevuto, et al.
British Journal of Cancer|August 5, 2004
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding studyC Ficorella, M F Morelli, E Ricevuto, et al.
Oncology Reports|April 6, 2006
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding studyC Ficorella, E Ricevuto, M F Morelli, et al.
Human Mutation|July 20, 2001
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancerF Baudi, B Quaresima, C Grandinetti, et al.
Journal of Medical Genetics|April 3, 2004
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutationsF Marroni, P Aretini, E D'Andrea, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
[Familiarity and heredity of tumors in function of an early surgical therapeutic approach]E Ricevuto, Z C Di Rocco, G Cianci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsC Capalbo, E Ricevuto, A Vestri, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Endocrinology|September 1, 1999
p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumoursM L Jaffrain-Rea, E Ferretti, E Toniato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Novel P53 mutations detected by FAMA in colorectal cancersF De Galitiis, K Cannita, A Tessitore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2007
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancerC Natoli, E Cianchetti, N Tinari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Prognostic value of p53 molecular status in high-risk primary breast cancerP Marchetti, K Cannita, E Ricevuto, et al.
British Journal of Cancer|August 5, 2004
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding studyC Ficorella, M F Morelli, E Ricevuto, et al.
Oncology Reports|April 6, 2006
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding studyC Ficorella, E Ricevuto, M F Morelli, et al.
Human Mutation|July 20, 2001
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancerF Baudi, B Quaresima, C Grandinetti, et al.
Journal of Medical Genetics|April 3, 2004
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutationsF Marroni, P Aretini, E D'Andrea, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
[Familiarity and heredity of tumors in function of an early surgical therapeutic approach]E Ricevuto, Z C Di Rocco, G Cianci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsC Capalbo, E Ricevuto, A Vestri, et al.
Pageof 5